ArrayJet specializes in advanced microarray technology, particularly through its patented inkjet microarrayers, which enable high-speed, high-density, and high-capacity printing of biological samples. This technology allows for the rapid and reproducible creation of microarrays, which can be utilized in various applications such as proteomics, genomics, and drug discovery. The inkjet microarrayers are designed to handle a wide range of biomolecules and substrates, providing flexibility in experimental design. Key features include the JetSpyder™ sample loading system, which minimizes waste and cross-contamination, and the Iris™ optical quality control system that ensures real-time monitoring and quality assurance during the printing process.

The Mercury systems, developed by ArrayJet, represent the culmination of over 20 years of innovation in microarray technology. These instruments are characterized by their robust piezoelectric printheads, which allow for contactless printing at impressive speeds, achieving up to 700 unique features per second. The systems are also equipped with advanced environmental controls to maintain optimal conditions for reproducibility and sample integrity. Additionally, ArrayJet offers a range of services, including custom microarray manufacturing and application expertise, making their technology accessible for various research and diagnostic needs.

United Kingdom

Arrayjet Ltd is accredited to ISO13485 and providesCRO/CMO liquid handling solutions to support a variety of microarray applications. Their high-speed microarray spotters utilize a patented, non-contact, inkjet technologyfor printing multiplex array-based assays onto slides, Point-Of-Care devices, biochips and microplates.COVID-19: Re-purposed its in-house antibody screening technology to create a population-scale diagnostic program that will help scientists better understand the behavior of the COVID-19 virus and further the rapidity of a global vaccination program.

ArrayJet

Company Details